De Bruin ML - Search Results

1

Prolonged QTc interval and risk of sudden cardiac death in a population of older adults.

Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, Deckers JW, Kingma JH, Sturkenboom MC, Stricker BH, Witteman JC. Straus SM, et al. Among authors: de bruin ml. J Am Coll Cardiol. 2006 Jan 17;47(2):362-7. doi: 10.1016/j.jacc.2005.08.067. J Am Coll Cardiol. 2006. PMID: 16412861 Free article.

2

QTc-prolonging drugs and hospitalizations for cardiac arrhythmias.

De Bruin ML, Hoes AW, Leufkens HG. De Bruin ML, et al. Am J Cardiol. 2003 Jan 1;91(1):59-62. doi: 10.1016/s0002-9149(02)02998-3. Am J Cardiol. 2003. PMID: 12505572

3

Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.

De Bruin ML, Dorresteijn LD, van't Veer MB, Krol AD, van der Pal HJ, Kappelle AC, Boogerd W, Aleman BM, van Leeuwen FE. De Bruin ML, et al. J Natl Cancer Inst. 2009 Jul 1;101(13):928-37. doi: 10.1093/jnci/djp147. Epub 2009 Jun 17. J Natl Cancer Inst. 2009. PMID: 19535773

4

Cardiac arrhythmias in adult patients with asthma.

Warnier MJ, Rutten FH, Kors JA, Lammers JW, de Boer A, Hoes AW, de Bruin ML. Warnier MJ, et al. Among authors: de boer a, de bruin ml. J Asthma. 2012 Nov;49(9):942-6. doi: 10.3109/02770903.2012.724132. Epub 2012 Sep 27. J Asthma. 2012. PMID: 23013453

5

Electrocardiographic characteristics of patients with chronic obstructive pulmonary disease.

Warnier MJ, Rutten FH, Numans ME, Kors JA, Tan HL, de Boer A, Hoes AW, De Bruin ML. Warnier MJ, et al. Among authors: de boer a, de bruin ml. COPD. 2013 Feb;10(1):62-71. doi: 10.3109/15412555.2012.727918. COPD. 2013. PMID: 23413894

6

Number of patients studied prior to approval of new medicines: a database analysis.

Duijnhoven RG, Straus SM, Raine JM, de Boer A, Hoes AW, De Bruin ML. Duijnhoven RG, et al. Among authors: de boer a, de bruin ml. PLoS Med. 2013;10(3):e1001407. doi: 10.1371/journal.pmed.1001407. Epub 2013 Mar 19. PLoS Med. 2013. PMID: 23526887 Free PMC article.

7

Increased risk of sudden cardiac arrest in obstructive pulmonary disease: a case-control study.

Warnier MJ, Blom MT, Bardai A, Berdowksi J, Souverein PC, Hoes AW, Rutten FH, de Boer A, Koster RW, De Bruin ML, Tan HL. Warnier MJ, et al. Among authors: de boer a, de bruin ml. PLoS One. 2013 Jun 6;8(6):e65638. doi: 10.1371/journal.pone.0065638. Print 2013. PLoS One. 2013. PMID: 23755262 Free PMC article.

8

Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases.

Vermeer NS, Straus SM, Mantel-Teeuwisse AK, Domergue F, Egberts TC, Leufkens HG, De Bruin ML. Vermeer NS, et al. Among authors: de bruin ml. Drug Saf. 2013 Aug;36(8):617-25. doi: 10.1007/s40264-013-0073-3. Drug Saf. 2013. PMID: 23771794

9

Long-term use of 5α-reductase inhibitors and the risk of male breast cancer.

Duijnhoven RG, Straus SM, Souverein PC, de Boer A, Bosch JL, Hoes AW, De Bruin ML. Duijnhoven RG, et al. Among authors: de boer a, de bruin ml. Cancer Causes Control. 2014 Nov;25(11):1577-82. doi: 10.1007/s10552-014-0455-6. Epub 2014 Aug 19. Cancer Causes Control. 2014. PMID: 25135615

10

Traceability of biologicals: present challenges in pharmacovigilance.

Vermeer NS, Spierings I, Mantel-Teeuwisse AK, Straus SM, Giezen TJ, Leufkens HG, Egberts TC, De Bruin ML. Vermeer NS, et al. Among authors: de bruin ml. Expert Opin Drug Saf. 2015 Jan;14(1):63-72. doi: 10.1517/14740338.2015.972362. Epub 2014 Nov 5. Expert Opin Drug Saf. 2015. PMID: 25369769 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page